首页>
外国专利>
AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES
AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES
展开▼
机译:沙美特罗和氟替卡松的气雾剂联合治疗呼吸系统疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: inhalation aerosol formulation for treating respiratory diseases contains salmeterol or salmeterol xinafoate, fluticasone or fluticasone propionate, a propellent modifier representing perfluorodecalin, and a propellent specified in 1,1,1,2 tetrafluoroethane (HFA-134a) and/or 1,1,1,2,3,3,3-heptafluoropropane (HPA-227ea).;EFFECT: higher respirable fraction and effective pulmonary delivery of the active ingredient; the aerosol has higher stability.;1 dwg, 6 ex
展开▼
机译:领域:药物;物质:用于治疗呼吸系统疾病的吸入气雾剂,包括沙美特罗或沙美特罗西那福酯,氟替卡松或丙酸氟替卡松,代表全氟萘烷的推进剂和在1,1,1,2四氟乙烷(HFA-134a)中指定的推进剂,以及/或1,1,1,2,3,3,3-七氟丙烷(HPA-227ea)。气溶胶具有更高的稳定性。; 1 dwg,6 ex
展开▼